// App-Quantinova.ai

: Baseline circulating soluble factors as predictors of immune-related adverse events (irAEs) in patients (pts) with metastatic clear cell renal carcinoma (mRCC) treated with nivolumab: A translational NIVOREN GETUG-AFU 26 study.

Researchers

Presenter

  • Lucia Carril-Ajuria

Principal Investigators

  • Marie Naigeon

  • Cécile Dalban

  • Aude Desnoyer

  • Nathalie Rioux-Leclercq

  • Catherine Sautès-Fridman

  • Maxime Meylan

  • Yann-Alexandre Vano

  • Benoit Beusenlick

  • Salem Chouaib

  • Caroline de Oliveira

  • Florence Tantot

  • Ronan Flippot

  • Bernard Escudier

  • Laurence Albiges

  • Nathalie Chaput

Medical Centers

  • Gustave Roussy, Villejuif, France

  • Pontchaillou University Hospital, Rennes, France

  • UNICANCER, Kremlin-Bicetre, France

  • Department of Medicine. Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France

  • Department of Medical Oncology, Hôpital Cochin, Institut du Cancer Paris CARPEM, AP-HP.Centre – Université Paris Cité, Paris, France

  • Department of Medical Oncology - Institut Gustave Roussy, Villejuif, France

  • Laboratory of Immunomonitoring in Oncology, Gustave Roussy, Villejuif, France

  • General Medical Oncology, University Hospitals Leuven, 3000 - Leuven/BE, Leuven, Belgium

  • Laboratoire D'immuno-oncologie, Gustave Roussy, 94800 - Villejuif/FR, Villejuif, France

  • Assistance Publique, Hopitaux de Paris, Hopital Tenon, Paris, France

  • Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Paris, France

  • Centre Leon Berard, Lyon, France

Locations

  • Belgium

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Metastatic Renal Cell Cancer

Biomarkers

  • B-cell activating factor

  • C-X-C Motif Chemokine Ligand 13

  • Lactate dehydrogenase

  • Vascular cell adhesion molecule 1

  • Vascular endothelial growth factor A

  • Interleukin 6

  • Interleukin-8

  • Interleukin-7

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved